Details.
A roundtable discussion titled "Formulation, Delivery, and Route-of-Administration Patents," moderated by firm partners Andrew D. Cohen and Lachlan S. Campbell-Verduyn. The discussion will explore how branded and biosimilar companies build, litigate, and defend formulation and delivery patents as core composition claims expire.